"New Treatment Guidelines And A New Biomarker In MS" - Stephen Krieger, MD
Stephen Krieger, MD, associate professor of neurology at the Icahn School of Medicine at Mount Sinai and a neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Mount Sinai Hospital, reports on two updates in multiple sclerosis (MS) that were presented at the 2018 American Academy of Neurology meeting in April. One of the updates from the meeting relates to how we currently practice MS care, and the other – a little more forward-looking – is about how this care may change in the near future. “The 2018 MS guideline recommendations are a great resource for the care of patients with MS. I also think we could cite these recommendations when helping our patients obtain third-party payer authorizations based on our treatment decisions,” said Dr. Krieger.
- Stephen Krieger, MD, Associate Professor, Neurology, Icahn School of Medicine at Mount Sinai, Neurologist, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Hospital